Today, a story about advances in treating the most deadly form of cancer: lung cancer. Those diagnosed will more than likely die within a year. Andy Bonnett, of Denver, was in his early 30's when he was told he had the disease. "I was actually quite shocked, and confused, and incredibly sad to hear those words," he said. That was two and a half years ago. Bonnett got very sick and progressed to the most advanced stage of the disease. But now, he's better, thanks to an experimental drug he's taking through the University of Colorado Cancer Center. It's called Crizotinib. And just 100 people on the planet are taking it. Thirty-five of them are doing so here in Colorado. For Andy Bonnett, and many others, the results have been extraordinary. Andy's with us along with Dr. Ross Camidge, the clinical director of UC-Denver's Lung Cancer program.
Promising New Cancer Drug at UC-Denver
A Growing Movement
Evergreen Members are transforming CPR with their powerful monthly commitment to in-depth journalism and music exploration. Thank you!
Listen to The Taxman
A new podcast from CPR News takes an in-depth look at Colorado’s Taxpayer’s Bill Of Rights—TABOR— considered either the worst thing that’s happened to the state, or the best.
Most Viewed News
By Vic Vela
By Sam Brasch
By Grace Hood